Generic Product Information: September 2022

September 30, 2022

This month’s generic product information options clorazepate dipotassium
tablets, exemestane tablets, and paliperidone extended-release tablets.

Paliperidone Prolonged-Launch Tablets

Marketed by Lupin Restricted

Evaluate To: Invega

The FDA has authorized Lupin Restricted’s abbreviated new drug utility for paliperidone extended-release tablets. The tablets are available 1.5-, 3-, 6-, and 9-mg strengths and are manufactured on the firm’s facility in Goa, India. Paliperidone extended-release tablets are the generic equal of Invega extended-release tablets in the identical strengths from Janssen Analysis and Improvement. Invega is indicated for the remedy of schizoaffective issues and schizophrenia.


Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

Marketed by Camber Corp

Evaluate To: Truvada

Camber Corp now presents emtricitabine and tenofovir disoproxil fumarate tablets. The generic is a mixture of two medication which are each HIV-1 nucleoside analogue reverse transcriptase inhibitors. It’s indicated together with different antiretroviral brokers for the remedy of HIV-1 an infection in each adults and kids who weigh not less than 17 kg. Camber is releasing the tablets within the 200-mg/300-mg power in 30-count bottles.


Clorazepate Dipotassium Tablets

Marketed by ANI Prescribed drugs

Evaluate To: Tranxene

The FDA authorized an abbreviated drug utility for clorazepate dipotassium tablets from ANI Prescribed drugs. The generic equal of Tranxene from Recordati Uncommon Illness Inc, clorazepate dipotassium is indicated for the administration of hysteria issues. Widespread adversarial occasions are despair, drowsiness, dry mouth, gastrointestinal complaints, complications, and insomnia. Tranxene is indicated for the administration of hysteria issues and for the short-term aid of hysteria signs. Additionally it is indicated for symptomatic aid of acute alcohol withdrawal and as an adjunctive remedy for partial seizures. The annual US marketplace for clorazepate dipotassium is roughly $25.8 million, in accordance with ANI Prescribed drugs.


Exemestane Tablets

Marketed by Aurobindo Pharma Restricted

Evaluate To: Aromasin

The FDA has authorized an abbreviated new drug utility for Aurobindo Pharma Restricted’s exemestane tablets within the 25-mg power. Exemestane tablets are the generic equal of Aromasin from Pfizer Inc and are indicated for the adjuvant remedy of postmenopausal girls with estrogen receptor–constructive early breast most cancers. The tablets are additionally indicated for the remedy of postmenopausal girls with superior breast most cancers whose illness has progressed following tamoxifen remedy. Exemestane is a steroidal irreversible aromatase inhibitor. The commonest adversarial occasions are fatigue, complications, sizzling flashes, elevated urge for food, joint ache, nausea, sweating, and hassle sleeping.


See also  The Hottest Pattern of 2022: Employee Strikes